Addressing a Rare Metabolic Disorder: The Carglumic Acid Market
The carglumic acid market, while representing a niche segment within the broader pharmaceutical landscape, plays a critical role in addressing a rare and life-threatening metabolic disorder: hyperammonemia due to N-acetylglutamate synthase (NAGS) deficiency
